Seattle Genetics up after hours on Q2 revenue beat

Seattle Genetics (NASDAQ:SGEN) Q2 results highlights:

Revenues: $218.4M (+28%); Adcetris sales: $159.0M (+30%).

Net loss: ($79.2M) (-204%).

2019 guidance: Total revenues: $805M – 855M from $790M – 840M; Adcetris sales: $610M – 640M (unch).

Shares are up 7% after hours.

https://seekingalpha.com/news/3478219-seattle-genetics-7-percent-hours-q2-revenue-beat